A Win For FibroGen, Inc.

Mon, Jan 29, 2024 at 07:16 PM

FibroGen, Inc. (FGEN:NASDAQ) jumped higher at $1.71, a gain of 82.7%. On Mon, Jan 29, 2024, FGEN:NASDAQ hit a New 2-Week High of $1.71. The stock appeared on our News Catalysts scanner on Thu, Jan 25, 2024 at 07:53 AM in the 'BIOTECH' category. From Tue, Jan 16, 2024, the stock recorded 66.67% Up Days and 80.00% Green Days

About FibroGen, Inc. (FGEN:NASDAQ)

FibroGen Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs.

Top 10 Gainers:

OneMedNet Corp. (ONMD:NASDAQ), 156.27%
Palisade Bio Inc. (PALI:NASDAQ), 83.21%
FibroGen, Inc. (FGEN:NASDAQ), 82.71%
NexImmune Inc. (NEXI:NASDAQ), 73.83%
Vinco Ventures Inc. (BBIG:NASDAQ), 55%
Rail Vision Ltd. (RVSN:NASDAQ), 54.63%
Connexa Sports Technologies Inc. (CNXA:NASDAQ), 43.69%
View Inc. (VIEW:NASDAQ), 41.03%
Selina Hospitality PLC (SLNA:NASDAQ), 38.04%
Atreca, Inc. (BCEL:NASDAQ), 35.7%